furosemide has been researched along with Glioma in 11 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A perifusion technique for microscopy with computerized detection of early changes in cell morphology during continuous perifusion was used to show that the geometry of cultured glioma cells (MG-251) changes rapidly when they are exposed to estramustine phosphate (EMP)." | 7.69 | Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion. ( Behnam-Motlagh, P; Engström, KG; Grankvist, K; Henriksson, R; Jonsson, O, 1997) |
| " Although bumetanide inhibition of Na-K-2Cl cotransport activity did not affect cell motility, treatment of glioma cells with furosemide to inhibit K-Cl cotransport activity prevented ~75% of wound closure in a reversible reaction." | 3.78 | High-grade glioma motility reduced by genetic knockdown of KCC3. ( Gagnon, KB, 2012) |
| "A perifusion technique for microscopy with computerized detection of early changes in cell morphology during continuous perifusion was used to show that the geometry of cultured glioma cells (MG-251) changes rapidly when they are exposed to estramustine phosphate (EMP)." | 3.69 | Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion. ( Behnam-Motlagh, P; Engström, KG; Grankvist, K; Henriksson, R; Jonsson, O, 1997) |
| " We describe the clinical course and management of each patient, including the long-term use of furosemide taken orally once a day." | 1.27 | Chronic syndrome of inappropriate secretion of antidiuretic hormone in childhood. ( David, R; Fertig, A; Sklar, C, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gagnon, KB | 1 |
| Johnson, JH | 1 |
| Dunn, DP | 1 |
| Rosenberg, RN | 1 |
| Wolpaw, EW | 1 |
| Martin, DL | 1 |
| Pinegin, LE | 1 |
| Dolzhenko, DA | 1 |
| Meinig, G | 1 |
| Sandström, PE | 1 |
| Jonsson, O | 2 |
| Grankvist, K | 2 |
| Henriksson, R | 2 |
| Behnam-Motlagh, P | 1 |
| Engström, KG | 1 |
| Sklar, C | 1 |
| Fertig, A | 1 |
| David, R | 1 |
| Chassande, O | 1 |
| Frelin, C | 1 |
| Farahifar, D | 1 |
| Jean, T | 1 |
| Lazdunski, M | 1 |
| Hayakawa, I | 1 |
| Kim, CS | 1 |
| Subedi, L | 1 |
| Park, KJ | 1 |
| Kim, SY | 1 |
| Choi, SU | 1 |
| Kim, KH | 1 |
| Lee, KR | 1 |
1 trial available for furosemide and Glioma
| Article | Year |
|---|---|
[Assessment of anti-oedematous therapy in brain tumour patients (author's transl)].
Topics: Brain Edema; Brain Neoplasms; Dexamethasone; Drug Therapy, Combination; Furosemide; Glioma; Humans; | 1980 |
10 other studies available for furosemide and Glioma
| Article | Year |
|---|---|
High-grade glioma motility reduced by genetic knockdown of KCC3.
Topics: Animals; Astrocytes; Cell Movement; Cells, Cultured; Furosemide; Gene Knockdown Techniques; Glioma; | 2012 |
Furosemide-sensitive K+ channel in glioma cells but not neuroblastoma cells in culture.
Topics: Animals; Biological Transport, Active; Cations, Monovalent; Cell Line; Furosemide; Glioma; Ion Chann | 1982 |
Cl- transport in a glioma cell line: evidence for two transport mechanisms.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Animals; Astrocytes; Bicarbonates; Cell | 1984 |
[Effect of furosemide on intracranial pressure in patients with intracranial hypertension].
Topics: Brain Diseases; Brain Neoplasms; Chlorides; Diuresis; Furosemide; Glioma; Humans; Intracranial Press | 1983 |
Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines.
Topics: Bumetanide; Cell Division; Estramustine; Furosemide; Glioma; Humans; Ion Transport; Lung Neoplasms; | 1994 |
Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.
Topics: Bumetanide; Cell Size; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estramustine; Furosemide | 1997 |
Chronic syndrome of inappropriate secretion of antidiuretic hormone in childhood.
Topics: Child, Preschool; Female; Furosemide; Glioma; Humans; Inappropriate ADH Syndrome; Infant, Newborn; M | 1985 |
The Na+/K+/Cl- cotransport in C6 glioma cells. Properties and role in volume regulation.
Topics: Biological Transport; Bumetanide; Carrier Proteins; Cells, Cultured; Chlorides; Flow Cytometry; Furo | 1988 |
[Clinical studies on a new intracranial pressure reducing agent].
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Diseases; Brain Injuries; Brain Neoplasms; Craniopharyng | 1967 |
Salicin derivatives from Salix glandulosa and their biological activities.
Topics: Animals; Benzyl Alcohols; Cell Line, Tumor; Cell Survival; Glioma; Glucosides; Mice; Microglia; Mole | 2015 |